News Sentiment

PMVP sentiment intelligence

Pmv Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 48 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 1.24 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

76/100 classification confidence.

Company focus 40

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+1.6% over one week, +11.7% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

ArrowMark Colorado Holdings (PMVP) holds 3.67% stake in PMV Pharmaceuticals

Market Reaction

Balanced read

61/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 76/100 classification
One-week reaction 1.6% Price digesting
Trend fit Trend inactive 11.7% over four weeks
Fair value -35.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 11
Neutral 35
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 40
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 9
Stock Titan 8
TradingView 8
TradingKey 6
GlobeNewswire 3
Moomoo 2
AD HOC NEWS 2
Insider Monkey 2

Event Lens

What the news is about

Classified themes
Market update 21
Earnings 17
Analyst action 5
Guidance 2
Deals and strategy 1
Capital return 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-48 of 48
Insider Monkey Direct company coverage

5 Popular Penny Stocks on Robinhood to Watch in 2026

PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) is highlighted as a popular penny stock on Robinhood. Oppenheimer recently reduced its price target on PMVP to $5, maintaining an Outperform rating, recognizing encouraging clinical activity for rezatapopt in cancer treatment. The company

Tone
Positive 59/100
Event
Analyst action
Published
31 May 2026 15:09
Source
Insider Monkey
FinancialContent Direct company coverage

PMV Pharmaceuticals, Inc. - Common Stock (Nasdaq:PMVP) Stock Quote

This page provides a stock quote and detailed financial information for PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), including its current price, trading volume, and 52-week range. It also features a feed of recent news and performance data for the company, highlighting drug develop

Tone
Neutral 50/100
Event
Market update
Published
16 May 2026 09:39
Source
FinancialContent
TradingView Direct company coverage

Number of shareholders of PMV Pharmaceuticals, Inc. – NASDAQ:PMVP

This article provides details on the number of shareholders for PMV Pharmaceuticals, Inc. (NASDAQ: PMVP). It is a financial data page from TradingView, explicitly stating the company's ticker and market. The content primarily focuses on presenting shareholder data with period, va

Tone
Neutral 50/100
Event
Market update
Published
15 May 2026 20:40
Source
TradingView